HIV PreventionIFE4PrEPNCT05087927
Study for IFE4PrEP Intervention on PrEP Uptake by Southern African American Women
An observational study of HIV Prevention, run by University of North Carolina, Chapel Hill at 1 site in United States.
Trial summary
Purpose: This study is partnering with communities to identify the best ways to provide HIV prevention communication and services for women living in public housing who have been disproportionately affected by HIV but underserved by current HIV prevention programs. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- HIV Prevention
- What is being tested?
- Gain framing plus demographically targeted photos, Loss framing plus demographically targeted photos and Gain framing plus not demographically targeted photos
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 31 participants
- Where
- 1 siteUnited States
- Study dates
- 18 Apr 2023to 10 Mar 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Study population: The target population for this study is African American cisgender women at least 18 years old residing in DHA (Durham Housing Authority) community housing. The vast majority of DHA residents are African American, so the investigators anticipate recruiting participants who are majority African American without explicitly excluding prospective participants on the basis of race.
Who may be able to join
- Women will be eligible to participate if they meet the following criteria:
- 18 years of age or older
- Identify as cisgender female (assigned female sex at birth and currently identify as female)
- Currently reside in Durham Housing Authority (DHA) housing
Who cannot join
- Women will not be eligible to participate if they meet the following criteria:
- Younger than 18 years of age
- Do not Identify as cisgender female (assigned female sex at birth and currently identify as female)
- Do not currently reside in Durham Housing Authority (DHA) housing
Trial locations and contacts
1 site in 1 country.
United States1 site
University of North Carolina
Chapel Hill, North Carolina, 27514
About this study
Official title: IGHID 12113 - Formative Study for I'm Fully Empowered4PrEP Intervention on HIV PrEP Uptake by Southern African American Women (IFE4PrEP Formative Study)
Purpose: This study is partnering with communities to identify the best ways to provide HIV prevention communication and services for women living in public housing who have been disproportionately affected by HIV but underserved by current HIV prevention programs. The investigators want to work with community members to develop and design the delivery of a program to promote awareness of and access to pre-exposure prophylaxis (PrEP) for HIV prevention among women living in public housing.
Participants: Up to 248 cisgender females who are 18 years of age or older and currently reside in Durham Housing Authority (DHA) housing will be enrolled in this study at UNC.
Procedures (methods): Data collection for this formative study will consist of 4 focus groups of up to 12 women in each focus group living in DHA as well as a survey of 200 women living in DHA.
Read the detailed description
Study Design
This observational formative study consists of cross-sectional data collection with women living in DHA (Durham Housing Authority) housing through surveys and focus group discussions. Both modes of data collection will service to collect descriptive information to refine the intervention. The survey will also include a randomized messaging experiment (see Data Collection Procedures description below).
Study Duration, Enrollment and Number of Subjects
This formative study will last up to one year (12 months). The investigators will enroll up to 248 participants (up to 200 survey participants and up to 48 focus group participants with some women participating in both) as recruitment allows and as necessitated by thematic saturation.
Study Population
The target population for this study is African American cisgender women at least 18 years old residing in DHA community housing. The vast majority of DHA residents are African American, so the investigators anticipate recruiting participants who are majority African American without explicitly excluding prospective participants on the basis of race. Women will be eligible to participate if they meet the following criteria:
- 18 years of age or older
- Identify as cisgender female (assigned female sex at birth and currently identify as female)
- Currently reside in Durham Housing Authority (DHA) housing
Data Collection Procedures
Survey
The self-administered electronic survey will assess the topics listed below and will include a randomized messaging experiment to assess the effect of exposure messaging about PrEP with variable framing on attitudes and perceived norms about PrEP. Participants will complete the survey as follows:
- Women recruited through community network referral may complete the survey on their own device at the time of their choosing.
- Women recruited through community/public events or FGDs will be provided the option to either: a) complete the self-administered electronic survey during the event on a study-owned device (if an in-person event). Limited literacy, vision-impaired, or any participant who desires assistance may request that a study staff member read the questions aloud to them for them to complete the survey, or request to complete the survey as an interviewer-administered survey in a private location; or b) complete the survey at a time of their choosing on their own device.
Survey topics will include:
- Sociodemographic characteristics (age, race/ethnicity, DHA community of residence)
- PrEP awareness \& knowledge
- Attitudes toward PrEP
- Randomized messaging experiment (see below)
- Perceived PrEP norms
- Perceived ability to access PrEP
- Barriers and facilitators to using PrEP
- Perceived HIV risk
- HIV risk factors/behaviors
- Likelihood to use PrEP/interest/willingness to use PrEP
- Perceived stigmas
The survey will include an embedded randomized 2 x 2 between-subjects experiment (gain vs. loss framing by intrinsic vs. extrinsic motivation messaging) evaluating the effects of the alternative messaging approaches on intermediate endpoints in Table 3 of the protocol to identify the approaches most associated with positive PrEP attitudes and norms. The experiment will be embedded in a questionnaire administered before focus group sessions to 40 focus group participants and to 160 additional women in study communities (total of 200, 50 per community). During each of the 4 focus groups, the investigators also will explore women's reactions to alternative modes (e.g., flyers, posters, apps, social media) of PrEP messaging.
Hypotheses for each messaging attribute are as follows:
H1: Gain framing will be associated with more positive attitudes and more positive perceived norms about PrEP than loss framing.
- Gain framing: PrEP puts me in control
- Loss framing: Without PrEP, I'm less in control
H2: Demographic targeting will be associated with more positive attitudes and more positive perceived norms about PrEP than non-demographically targeted messaging.
- Demographically targeted: [Image of African American woman]
- Extrinsic framing: [Image of women of multiple races]
Focus Group Discussions (FGDs)
Focus Group participants will be given the option to participate in a focus group by Zoom or in person. Per North Carolina Executive Orders current at the time of data collection, the investigators anticipate that in-person FGDs will be conducted in a private indoor location with sufficient ventilation, 6-foot distancing between participants, and with face masks for both FGD facilitators and participants. Focus groups with limited participants showing up may be converted to individual in-depth interviews. With participant consent, FGDs will be audio-recorded for analysis. Zoom focus groups will be video/audio-recorded with the video deleted and the audio retained directly following the FGD. Focus groups will be led by trained study staff members who will facilitate a discussion on the topics below:
- Current awareness \& knowledge of PrEP (including current sources of information about PrEP)
- Attitudes toward PrEP (including any stigmas about PrEP, perceived risk)
- Perceptions of and recommendations for messaging about PrEP use among cisgender women (open-ended then specific reactions)
- Perceptions of and recommendations for messaging about PrEP mobile unit (open-ended then specific reactions)
- Preferences for mobile PrEP unit delivery features (e.g., timing, location, appointment type, delivery of complementary services).
- Best media/modes for providing messages about PrEP and the mobile unit to women in DHA.
- Perceptions of peer networkers, best approach for contacting residents and providing information.
- Barriers and facilitators to using PrEP
- Conditions
- HIV Prevention
- Being tested
- Gain framing plus demographically targeted photos, Loss framing plus demographically targeted photos, Gain framing plus not demographically targeted photos, Loss framing plus not demographically targeted photos
- Keywords
- HIV, pre-exposure prophylaxis, PrEP, Prevention, Women's Health, Health Messaging
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Gain framing plus demographically targeted photosBehavioural
Gain framing: Participant feels PrEP puts her in control
Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Loss framing plus demographically targeted photosBehavioural
Loss framing: Without PrEP, participant feels less in control
Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Gain framing plus not demographically targeted photosBehavioural
Gain framing: Participant feels PrEP puts her in control
Participants (majority of whom will be African American) will be shown an image of an African American woman.
Loss framing plus not demographically targeted photosBehavioural
Loss framing: Without PrEP, participant feels less in control
Participants (majority of whom will be African American) will be shown an image of an African American woman.
| Study group | Role | What they receive |
|---|---|---|
| Focus Group | There will be 4 focus groups of up to 12 women in each focus group. Receives: Behavioral: Gain framing plus demographically targeted photos; Behavioral: Loss framing plus demographically targeted photos; Behavioral: Gain framing plus not demographically targeted photos; Behavioral: Loss framing plus not demographically targeted photos | |
| Survey Group | There will be up to 200 women who complete the survey for this study. Receives: Behavioral: Gain framing plus demographically targeted photos; Behavioral: Loss framing plus demographically targeted photos; Behavioral: Gain framing plus not demographically targeted photos; Behavioral: Loss framing plus not demographically targeted photos |
What is being measured
The primary outcome is the main question the study is designed to answer.
Modified Jaspal, Lopes, and Maatouk Attitudes toward PrEP Scale (APS)
A subset of the Attitudes toward PrEP Scale (APS) will be used to assess the association between message exposure and attitudes toward pre-exposure prophylaxis (PrEP). This sub-set scale will include nine items rated on a 5-point Likert scale (responses ranging from 1=Strongly Disagree to 5=Strongly Agree). The nine items are a sub-set of the original APS scale and will include four items comprising sub-scale 2, three items comprising sub-scale 3, and two items from sub-scale 1. A mean score will be calculated for each complete sub-scale (2 and 3) ranging from 1-5. Each of the two items from sub-scale 1 will be scored individually, ranging from 1-5. Higher scores indicate more positive attitudes toward PrEP.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Oct 2021
- Study start18 Apr 2023
- Primary completion28 Nov 2023
- Study completion10 Mar 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HIV PreventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University, hospital or other
- Collaborators
- Gilead Sciences
- Responsible party
- Sponsor
- Investigators
- Carol Golin, MD, Principal investigator, UNC-Chapel HillLauren Hill, PhD, Principal investigator, UNC-Chapel Hill
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05087927
- Sponsor's protocol ID
- 21-1244
- Acronym
- IFE4PrEP
- Status last verified
- Sep 2024
- First submitted
- 8 Oct 2021
- Last updated
- 20 Sep 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- IGHID 12113 - Formative Study for I'm Fully Empowered4PrEP Intervention on HIV PrEP Uptake by Southern African American Women (IFE4PrEP Formative Study)
- ClinicalTrials.gov ID
- NCT05087927
- Acronym / sponsor ID
- IFE4PrEP / 21-1244
- Conditions
- HIV Prevention
- Keywords
- HIV, pre-exposure prophylaxis, PrEP, Prevention, Women's Health, Health Messaging
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- University of North Carolina, Chapel HillUniversity, hospital or other
- Collaborators
- Gilead Sciences
- Study start
- 18 Apr 2023 (actual)
- Primary completion
- 28 Nov 2023 (actual)
- Study completion
- 10 Mar 2024 (actual)
- First posted
- 21 Oct 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Purpose: This study is partnering with communities to identify the best ways to provide HIV prevention communication and services for women living in public housing who have been disproportionately affected by HIV but underserved by current HIV prevention programs. The investigators want to work with community members to develop and design the delivery of a program to promote awareness of and access to pre-exposure prophylaxis (PrEP) for HIV prevention among women living in public housing.
Participants: Up to 248 cisgender females who are 18 years of age or older and currently reside in Durham Housing Authority (DHA) housing will be enrolled in this study at UNC.
Procedures (methods): Data collection for this formative study will consist of 4 focus groups of up to 12 women in each focus group living in DHA as well as a survey of 200 women living in DHA.
Detailed description
Study Design
This observational formative study consists of cross-sectional data collection with women living in DHA (Durham Housing Authority) housing through surveys and focus group discussions. Both modes of data collection will service to collect descriptive information to refine the intervention. The survey will also include a randomized messaging experiment (see Data Collection Procedures description below).
Study Duration, Enrollment and Number of Subjects
This formative study will last up to one year (12 months). The investigators will enroll up to 248 participants (up to 200 survey participants and up to 48 focus group participants with some women participating in both) as recruitment allows and as necessitated by thematic saturation.
Study Population
The target population for this study is African American cisgender women at least 18 years old residing in DHA community housing. The vast majority of DHA residents are African American, so the investigators anticipate recruiting participants who are majority African American without explicitly excluding prospective participants on the basis of race. Women will be eligible to participate if they meet the following criteria:
- 18 years of age or older
- Identify as cisgender female (assigned female sex at birth and currently identify as female)
- Currently reside in Durham Housing Authority (DHA) housing
Data Collection Procedures
Survey
The self-administered electronic survey will assess the topics listed below and will include a randomized messaging experiment to assess the effect of exposure messaging about PrEP with variable framing on attitudes and perceived norms about PrEP. Participants will complete the survey as follows:
- Women recruited through community network referral may complete the survey on their own device at the time of their choosing.
- Women recruited through community/public events or FGDs will be provided the option to either: a) complete the self-administered electronic survey during the event on a study-owned device (if an in-person event). Limited literacy, vision-impaired, or any participant who desires assistance may request that a study staff member read the questions aloud to them for them to complete the survey, or request to complete the survey as an interviewer-administered survey in a private location; or b) complete the survey at a time of their choosing on their own device.
Survey topics will include:
- Sociodemographic characteristics (age, race/ethnicity, DHA community of residence)
- PrEP awareness \& knowledge
- Attitudes toward PrEP
- Randomized messaging experiment (see below)
- Perceived PrEP norms
- Perceived ability to access PrEP
- Barriers and facilitators to using PrEP
- Perceived HIV risk
- HIV risk factors/behaviors
- Likelihood to use PrEP/interest/willingness to use PrEP
- Perceived stigmas
The survey will include an embedded randomized 2 x 2 between-subjects experiment (gain vs. loss framing by intrinsic vs. extrinsic motivation messaging) evaluating the effects of the alternative messaging approaches on intermediate endpoints in Table 3 of the protocol to identify the approaches most associated with positive PrEP attitudes and norms. The experiment will be embedded in a questionnaire administered before focus group sessions to 40 focus group participants and to 160 additional women in study communities (total of 200, 50 per community). During each of the 4 focus groups, the investigators also will explore women's reactions to alternative modes (e.g., flyers, posters, apps, social media) of PrEP messaging.
Hypotheses for each messaging attribute are as follows:
H1: Gain framing will be associated with more positive attitudes and more positive perceived norms about PrEP than loss framing.
- Gain framing: PrEP puts me in control
- Loss framing: Without PrEP, I'm less in control
H2: Demographic targeting will be associated with more positive attitudes and more positive perceived norms about PrEP than non-demographically targeted messaging.
- Demographically targeted: [Image of African American woman]
- Extrinsic framing: [Image of women of multiple races]
Focus Group Discussions (FGDs)
Focus Group participants will be given the option to participate in a focus group by Zoom or in person. Per North Carolina Executive Orders current at the time of data collection, the investigators anticipate that in-person FGDs will be conducted in a private indoor location with sufficient ventilation, 6-foot distancing between participants, and with face masks for both FGD facilitators and participants. Focus groups with limited participants showing up may be converted to individual in-depth interviews. With participant consent, FGDs will be audio-recorded for analysis. Zoom focus groups will be video/audio-recorded with the video deleted and the audio retained directly following the FGD. Focus groups will be led by trained study staff members who will facilitate a discussion on the topics below:
- Current awareness \& knowledge of PrEP (including current sources of information about PrEP)
- Attitudes toward PrEP (including any stigmas about PrEP, perceived risk)
- Perceptions of and recommendations for messaging about PrEP use among cisgender women (open-ended then specific reactions)
- Perceptions of and recommendations for messaging about PrEP mobile unit (open-ended then specific reactions)
- Preferences for mobile PrEP unit delivery features (e.g., timing, location, appointment type, delivery of complementary services).
- Best media/modes for providing messages about PrEP and the mobile unit to women in DHA.
- Perceptions of peer networkers, best approach for contacting residents and providing information.
- Barriers and facilitators to using PrEP
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Focus Group | – | Behavioral: Gain framing plus demographically targeted photos, Behavioral: Loss framing plus demographically targeted photos, Behavioral: Gain framing plus not demographically targeted photos, Behavioral: Loss framing plus not demographically targeted photosThere will be 4 focus groups of up to 12 women in each focus group. |
| Survey Group | – | Behavioral: Gain framing plus demographically targeted photos, Behavioral: Loss framing plus demographically targeted photos, Behavioral: Gain framing plus not demographically targeted photos, Behavioral: Loss framing plus not demographically targeted photosThere will be up to 200 women who complete the survey for this study. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The target population for this study is African American cisgender women at least 18 years old residing in DHA (Durham Housing Authority) community housing. The vast majority of DHA residents are African American, so the investigators anticipate recruiting participants who are majority African American without explicitly excluding prospective participants on the basis of race.
Key inclusion criteria (4 listed)
- 18 years of age or older
- Identify as cisgender female (assigned female sex at birth and currently identify as female)
- Currently reside in Durham Housing Authority (DHA) housing
Key exclusion criteria (4 listed)
- Younger than 18 years of age
- Do not Identify as cisgender female (assigned female sex at birth and currently identify as female)
- Do not currently reside in Durham Housing Authority (DHA) housing
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Gain framing plus demographically targeted photosGain framing: Participant feels PrEP puts her in control Participants (majority of whom will be African American) will be shown an image of women of multiple races. | Behavioural | Focus Group, Survey Group |
| Loss framing plus demographically targeted photosLoss framing: Without PrEP, participant feels less in control Participants (majority of whom will be African American) will be shown an image of women of multiple races. | Behavioural | Focus Group, Survey Group |
| Gain framing plus not demographically targeted photosGain framing: Participant feels PrEP puts her in control Participants (majority of whom will be African American) will be shown an image of an African American woman. | Behavioural | Focus Group, Survey Group |
| Loss framing plus not demographically targeted photosLoss framing: Without PrEP, participant feels less in control Participants (majority of whom will be African American) will be shown an image of an African American woman. | Behavioural | Focus Group, Survey Group |
Primary outcome
Modified Jaspal, Lopes, and Maatouk Attitudes toward PrEP Scale (APS)
Time frame: Baseline
A subset of the Attitudes toward PrEP Scale (APS) will be used to assess the association between message exposure and attitudes toward pre-exposure prophylaxis (PrEP). This sub-set scale will include nine items rated on a 5-point Likert scale (responses ranging from 1=Strongly Disagree to 5=Strongly Agree). The nine items are a sub-set of the original APS scale and will include four items comprising sub-scale 2, three items comprising sub-scale 3, and two items from sub-scale 1. A mean score will be calculated for each complete sub-scale (2 and 3) ranging from 1-5. Each of the two items from sub-scale 1 will be scored individually, ranging from 1-5. Higher scores indicate more positive attitudes toward PrEP.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Sep 2024.
- Individual participant dataSharing planned: No
Related trials for HIV Prevention
Not yet recruitingPhase 4
Starting HIV Prevention Medicine (PrEP) During an Emergency Department Visit With a Peer Navigator
HIV Prevention, Pre-Exposure Prophylaxis (PrEP)
Active, not recruiting
Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda
HIV Prevention
Not yet recruiting
Evaluating the Healthy Families PrEP Program for Women at Risk for HIV
HIV, Pregnancy
Recruiting
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
HIV Infections
Active, not recruiting
IGHID 12230 - An Implementation Trial of an Experiential Brief Alcohol Intervention for HIV Prevention
HIV-1-infection, Unhealthy Alcohol Use
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carol Golin, MD principal investigator
UNC-Chapel Hill
Lauren Hill, PhD principal investigator
UNC-Chapel Hill
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of HIV Prevention, run by University of North Carolina, Chapel Hill at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Modified Jaspal, Lopes, and Maatouk Attitudes toward PrEP Scale (APS) (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Sep 2024.